Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

2,331 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Genetics of Crohn disease, an archetypal inflammatory barrier disease.
Schreiber S, Rosenstiel P, Albrecht M, Hampe J, Krawczak M. Schreiber S, et al. Nat Rev Genet. 2005 May;6(5):376-88. doi: 10.1038/nrg1607. Nat Rev Genet. 2005. PMID: 15861209 Review.
The interferon-gamma gene as a positional and functional candidate gene for inflammatory bowel disease.
Hampe J, Hermann B, Bridger S, MacPherson AJ, Mathew CG, Schreiber S. Hampe J, et al. Among authors: schreiber s. Int J Colorectal Dis. 1998;13(5-6):260-3. doi: 10.1007/s003840050173. Int J Colorectal Dis. 1998. PMID: 9870173
The transmission disequilibrium test for association was negative (P > or = 0.22) for Crohn's disease, ulcerative colitis, and the combined inflammatory bowel disease phenotype. ...
The transmission disequilibrium test for association was negative (P > or = 0.22) for Crohn's disease, ulcerative colitis, and the …
Experimental immunomodulatory therapy of inflammatory bowel disease.
Schreiber S. Schreiber S. Neth J Med. 1998 Dec;53(6):S24-31. doi: 10.1016/s0300-2977(98)00120-x. Neth J Med. 1998. PMID: 9883011 Review.
Crohn's disease and ulcerative colitis are chronic inflammatory bowel diseases (IBD) of unknown etiology but demonstrate a rising incidence in many western countries. ...Although the precise mechanism of action is not completely understood, it appears that a single infusio …
Crohn's disease and ulcerative colitis are chronic inflammatory bowel diseases (IBD) of unknown etiology but demonstrate a rising inc …
Activation of nuclear factor kappaB as a target for anti-inflammatory therapy.
Schreiber S. Schreiber S. Gut. 1999 Mar;44(3):309-10. doi: 10.1136/gut.44.3.309. Gut. 1999. PMID: 10026311 Free PMC article. No abstract available.
A genomewide analysis provides evidence for novel linkages in inflammatory bowel disease in a large European cohort.
Hampe J, Schreiber S, Shaw SH, Lau KF, Bridger S, Macpherson AJ, Cardon LR, Sakul H, Harris TJ, Buckler A, Hall J, Stokkers P, van Deventer SJ, Nürnberg P, Mirza MM, Lee JC, Lennard-Jones JE, Mathew CG, Curran ME. Hampe J, et al. Among authors: schreiber s. Am J Hum Genet. 1999 Mar;64(3):808-16. doi: 10.1086/302294. Am J Hum Genet. 1999. PMID: 10053016 Free PMC article.
Linkage of inflammatory bowel disease to human chromosome 6p.
Hampe J, Shaw SH, Saiz R, Leysens N, Lantermann A, Mascheretti S, Lynch NJ, MacPherson AJ, Bridger S, van Deventer S, Stokkers P, Morin P, Mirza MM, Forbes A, Lennard-Jones JE, Mathew CG, Curran ME, Schreiber S. Hampe J, et al. Among authors: schreiber s. Am J Hum Genet. 1999 Dec;65(6):1647-55. doi: 10.1086/302677. Am J Hum Genet. 1999. PMID: 10577918 Free PMC article.
Inflammatory bowel disease: immunologic concepts.
Schreiber S. Schreiber S. Hepatogastroenterology. 2000 Jan-Feb;47(31):15-28. Hepatogastroenterology. 2000. PMID: 10690582 Review.
., the monoclonal antibody infliximab), have been introduced into the therapeutic management of Crohn's disease. With our increasing knowledge of disease pathophysiology and the identification of key mediators, it is to be expected that the efficacy of anti-inflammatory th …
., the monoclonal antibody infliximab), have been introduced into the therapeutic management of Crohn's disease. With our increasing …
Anticipation in inflammatory bowel disease: a phenomenon caused by an accumulation of confounders.
Hampe J, Heymann K, Kruis W, Raedler A, Fölsch UR, Schreiber S. Hampe J, et al. Among authors: schreiber s. Am J Med Genet. 2000 May 29;92(3):178-83. doi: 10.1002/(sici)1096-8628(20000529)92:3<178::aid-ajmg4>3.0.co;2-p. Am J Med Genet. 2000. PMID: 10817651
2,331 results
Jump to page
Feedback